🔗 Share this article

While the United States undertakes unprecedented revisions to its immunization recommendations, an unexpected name appears in a surprising turn: Dr. Tracy Beth Høeg, a US-based sports physician and public health researcher who first made her name by questioning Covid vaccines during the global health crisis and has zeroed in on alleged fatalities after COVID-19 vaccination in her recent tenure at the US Food and Drug Administration (FDA).

Scheduled Overhauls to Pediatric Immunization Program

Agency leaders had intended to reveal radical revisions to the childhood vaccination calendar earlier this month, synchronizing the US with the Danish immunization schedule, sources say – a significant shift that would put the US out of step with a large portion of the global community with no evidence for public health gain. The planned update has been postponed until the coming year.

In place of Vinay Prasad, Tracy Beth Høeg is scheduled to speak at the gathering. She was just designated acting director of the FDA’s Center for Drug Evaluation and Research (CDER), the fifth appointee to lead the office this year.

A New Direction at the FDA

Høeg's temporary position could signify a tighter collaboration between the pharmaceutical and biologics branches as Høeg and Dr. Prasad consolidate power at the FDA – and it points to a renewed priority upon reevaluating long-standing immunizations at the FDA.

The new acting director has repeatedly called for ending certain childhood shot schedules in the US so as to align more in line with Denmark's approach, a society with comprehensive healthcare and a citizenry about the size of the state of Wisconsin.

In her initial public appearances, she has persisted in emphasizing on immunizations – typically the responsibility of Dr. Prasad, head of the FDA’s vaccine center – instead of drug regulation.

Doubts Over Background

Høeg has no obvious background in medication creation, oversight or administrative roles, which has been standard for former leaders of the Center for Biologics Evaluation and Research. She has served at the FDA as a key advisor to the agency head and the vaccine center since earlier this year.

“She doesn’t seem to have any of the qualifications” for leading the drug-regulation department, stated a neurologist and psychiatrist. “She has not conducted a randomized controlled trial. She is not versed in managing a major agency. She has no expertise in drug approvals.”

Previous heads of CBER would “grasp legal statutes and the underlying principles of pharmaceutical innovation”, said a former acting FDA commissioner. “Objectively, she doesn’t have the type of experience that former directors who headed CBER have had.”

The drug center has an immense workload at the FDA, the former commissioner pointed out.

“Everybody just zeroes in on the novel medication approvals, but the generic program clears thousands of generic medications. There’s a biologic copycat branch, OTC medication office and so forth, and all of those need to be looked after,” she explained. “The responsibility you don’t keep your eye on, that’s the thing that I always told people is going to cause problems.”

There is also, a major administrative component to the role, which manages over 5,000 personnel. “It is a huge management job, if you execute it properly,” she concluded.

Agency Reaction and Controversial Policies

Regarding concerns about Høeg’s qualifications and whether this appointment indicates increased cooperation among agency officials on immunizations, a representative responded that the “concerns rely on inaccurate premises”.

“Her experience is consistent with the functions of her job,” the spokesperson explained, citing the months Dr. Høeg spent guiding the FDA commissioner on “pharmaceutical safety and oversight research, including computational safety modeling and vaccine surveillance”.

As the temporary head, Høeg assumes responsibility for the agency head's controversial fast-track approval initiative, a controversial one-day medication authorization process that allegedly troubled her former heads. “How are these drugs being selected for this expedited pathway? Who makes the calls?” Howard asked. “There’s a lot of lack of transparency occurring at the regulatory body right now.”

Overall, he remarked, “the agency seems to be moving towards more relaxed regulations of most medications, aside from vaccines.”

Documented Past Work on Immunizations

Regarding vaccines, Høeg has a more established, if concerning, track record, some experts observe. She released a analysis using unconfirmed crowd-sourced reports to estimate the frequency of myocarditis following Covid immunization. She consulted for the Florida surgeon general Joseph Ladapo, who allegedly have modified findings to indicate COVID-19 vaccinations are more dangerous than they are.

Part of her “desired changes” for the current government featured changing rules for new vaccines and discontinuing “unnecessary” immunizations, she stated post-election on a podcast. At the FDA, Høeg has according to sources suggested barring teenage boys from obtaining COVID-19 vaccines.

“She is an thorough dogmatist who begins with her preconceived notions and reverse-engineers to retrofit the data in a highly disingenuous, dishonest way,” Howard said.

Consolidating Power and a “Revenge Tour”

Dr. Høeg aligned with fellow skeptics, {like|